Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OmniAb, Inc. | 40,000 | reported | 17 Jun 2025 | tx 23+507,110−43,792 |
| LIGAND PHARMACEUTICALS INC | 1,161 | reported | 01 Nov 2022 | tx 6+11,013−5,344 |
1 purchase reported after at least 12 months of silence — most recent on 15 May 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2025 | EXERCISE | OmniAb, Inc. | 20,000 | — | |
| 17 Jun 2025 | EXERCISE | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 15 May 2025 | PURCHASE | OmniAb, Inc. | 30,000 | 1.52 USD | first after silence |
| 12 Jul 2024 | EXERCISE | OmniAb, Inc. | 1,896 | — | |
| 12 Jul 2024 | EXERCISE | OmniAb, Inc. | 1,896 | 0.00 USD | deriv |
| 18 Jun 2024 | EXERCISE | OmniAb, Inc. | 20,000 | — | |
| 18 Jun 2024 | EXERCISE | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 12 Jul 2023 | EXERCISE | OmniAb, Inc. | 1,896 | — | |
| 12 Jul 2023 | EXERCISE | OmniAb, Inc. | 1,896 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 30 Jan 2023 | GRANT_AWARD | OmniAb, Inc. | 17,506 | 0.00 USD | |
| 30 Jan 2023 | GRANT_AWARD | OmniAb, Inc. | 75,680 | 0.00 USD | deriv |
| 06 Dec 2022 | PURCHASE | OmniAb, Inc. | 22,250 | 3.75 USD | |
| 11 Nov 2022 | PURCHASE | OmniAb, Inc. | 30,000 | 3.10 USD | |
| 01 Nov 2022 | OTHER | LIGAND PHARMACEUTICALS INC | 1,004 | — | |
| 01 Nov 2022 | OTHER | LIGAND PHARMACEUTICALS INC | 4,340 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 25,226 | — | |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 37,840 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 19,298 | — | deriv |
| 10 Jun 2022 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,004 | 0.00 USD |